Tribute Plan Summary
The Tribute Plan is an unrivaled financial benefit that rewards you for your loyalty to The Doctors Company and for your dedication to superior patient care.
Search
The Tribute Plan Frequently Asked Questions
The Tribute Plan is a breakthrough financial benefit that rewards eligible members for their loyalty to The Doctors Company and for their commitment to superior patient care.
Marginalized Groups and the Digital Divide
Artificial intelligence (AI) has potential to help alleviate clinician burnout and address health disparities, but some technologies might not be accessible to all groups. Kevin Johnson, MD, MS, University Professor of Biomedical Informatics, Computer Science, Pediatrics, and Science Communication at the University of Pennsylvania, Vice President of Applied Clinical Informatics in the Penn Medicine, University of Pennsylvania Health System, shares insights during TDC Group’s 2024 Executive Advisory Board Meeting.
Jun 05, 2023
Driving Positive Outcomes in the Professional Liability Advocacy Arena
It is imperative for healthcare practitioners to weigh in on legislative matters involving healthcare provision and access. These expert tips can help you engage with policymakers and communicate effectively.
From
The Doctor’s Advocate
Jun 05, 2023
Industry and Company News Second Quarter 2023
Announcements in the second quarter of 2023 include our 2023 member dividend and a new study on the effects of social inflation.
From
The Doctor’s Advocate
COVID-19 Tribute Award Donation
Richard A. Bond, DO, FAAFM, who recently retired from family practice, donated the entirety of his Tribute® Plan award to the emergency fund of his medical school alma mater, California’s Western University of Health Sciences.
Effective Obstetrical Team Communication
Effective communication requires a team effort for the exchange of concise and relevant information.
December 01, 2024, South Florida Hospital News and Healthcare Report
The Rising Threat of Nuclear Verdicts in Medical Malpractice: A Call for Tort Reform
Dr. Patricia Ares-Romero discusses the increasing trend of "nuclear verdicts"—jury awards exceeding $10 million—in medical malpractice cases. She highlights insights from Bob White, President of The Doctors Company and TDC Group, noting that from 2013 to 2023, these verdicts surged by 67%, with the average award among the top 50 malpractice verdicts rising from $32 million in 2022 to $48 million in 2023.
Exclusively Endorsed by ASPS
The American Society of Plastic Surgeons exclusively endorses The Doctors Company. ASPS members receive unique benefits, including exclusive program discounts and credits.
September 11, 2025, KevinMD
Nuclear Verdicts and Rising Costs: How Inflation Is Reshaping Medical Malpractice Claims
Physicians today face mounting challenges in the practice of medicine, including declining reimbursement, workforce shortages, administrative burdens, and the ever-present risk of litigation. The Doctors Company’s latest study, “Nuclear Verdicts and Rising Costs: How Inflation Is Impacting Medical Malpractice Claims,” highlights another pressure point: the accelerating impact of inflation on medical malpractice claims.
